Literature DB >> 2325733

Enhanced local production of complement components in the small intestines of patients with Crohn's disease.

O Ahrenstedt1, L Knutson, B Nilsson, K Nilsson-Ekdahl, B Odlind, R Hällgren.   

Abstract

There is evidence that complement components may be formed locally in inflammatory lesions containing monocytes and macrophages. To investigate the role of complement in Crohn's disease we measured jejunal-fluid concentrations of the complement components C4, C3, and factor B by perfusion of a closed segment of the jejunum in 22 patients with Crohn's disease thought to be limited to the terminal ileum. The mean (+/- SEM) jejunal-fluid C4 concentration was 2.0 +/- 0.3 mg per liter, significantly higher than the mean level in 35 healthy controls (0.7 +/- 0.1 mg per liter; P less than 0.001). The mean C3 concentration was 1.0 +/- 0.1 mg per liter in the patients and 0.7 +/- 0.1 mg per liter in the controls (P less than 0.05). The factor B levels were similar in the two groups. Calculated rates of intestinal secretion of these components showed differences of the same magnitude. Leakage of protein from plasma was not increased. The jejunal-fluid:serum ratios of these complement proteins indicated that their appearance in the lumen of the jejunum was due to at least in part to local mucosal synthesis. The increased jejunal secretion of C4, but not C3 or factor B, paralleled the clinical activity of Crohn's disease. Values were normal in first-degree relatives of the patients (n = 13), patients with celiac disease (n = 8), and patients with ulcerative colitis (n = 4). We conclude that increased secretion of complement by clinically unaffected jejunal tissue in patients with Crohn's disease reflects the systemic nature of this disorder and may be due to the stimulated synthesis of complement by activated intestinal monocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2325733     DOI: 10.1056/NEJM199005103221903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  47 in total

1.  Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease.

Authors:  J Laufer; R Oren; I Goldberg; A Horwitz; J Kopolovic; Y Chowers; J H Passwell
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

2.  Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.

Authors:  T S Halstensen; T E Mollnes; P Garred; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  Circulating von Willebrand factor in inflammatory bowel disease.

Authors:  T R Stevens; J P James; N J Simmonds; D A McCarthy; I F Laurenson; P J Maddison; D S Rampton
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

4.  Cell recovery during segmental intestinal perfusion in healthy subjects and patients with Crohn's disease.

Authors:  O Ahrenstedt; F Knutson; L Knutson; M Krog; O Sjöberg; R Hällgren
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

5.  Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?

Authors:  J D Söderholm; G Olaison; E Lindberg; U Hannestad; A Vindels; C Tysk; G Järnerot; R Sjödahl
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

6.  A cross-ethnic survey of CFB and SLC44A4, Indian ulcerative colitis GWAS hits, underscores their potential role in disease susceptibility.

Authors:  Aditi Gupta; Garima Juyal; Ajit Sood; Vandana Midha; Keiko Yamazaki; Arnau Vich Vila; Motohiro Esaki; Toshiyuki Matsui; Atsushi Takahashi; Michiaki Kubo; Rinse K Weersma; B K Thelma
Journal:  Eur J Hum Genet       Date:  2016-10-19       Impact factor: 4.246

7.  Neutrophils migrate across intestinal epithelium using beta2 integrin (CD11b/CD18)-independent mechanisms.

Authors:  K M Blake; S O Carrigan; A C Issekutz; A W Stadnyk
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

8.  Cellular specificity of murine renal C3 expression in two models of inflammation.

Authors:  B H Ault; H R Colten
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

9.  The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

Authors:  T Sugihara; A Kobori; H Imaeda; T Tsujikawa; K Amagase; K Takeuchi; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

10.  Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium.

Authors:  E P Molmenti; D H Perlmutter; D C Rubin
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.